In my July 29 post, I reviewed RTX Corporation (RTX) following the release of Q2 and YTD2023 results. In releasing Q2 results, RTX informed the investment community that its Pratt & Whitney (P&W) operating segment identified microscopic contaminants in a metal used in part of the Geared Turbofan (GTF) engines that power Airbus' popular A320neo [...]
I last reviewed Thermo Fisher Scientific (TMO) in this August 2 post at which time Q2 and YTD2023 results had recently been released; I concluded shares were overvalued at ~$544. Following that post: TMO completed the CorEvitas acquisition I touched upon in my previous post. Novo Nordisk hired TMO to help fill the injection pens [...]
In my August 26 Rollins (ROL) post, I reference the company's $1.5B shelf registration. One of the purposes of this shelf registration was to provide the company with liquidity to help the Rollins family divest a portion of their holdings. I concluded that post by stating 'Although ROL shares are not inexpensive, I intend to [...]
I last reviewed Lockheed Martin (LMT) in this July 19 post at which time LMT had just raised its FY2023 adjusted diluted EPS guidance to ~$27.00 – ~$27.20 from the prior ~$26.60 - ~$26.90 guidance. Based on my assessment, I increased my exposure by 50 shares in one of the 'Core' accounts within the FFJ [...]
HEICO Corporation has two classes of common stock (HEI and HEI.a). Both classes of shares are virtually identical in all economic respects except voting rights. The difference is that each HEI share is entitled to one vote per share while each HEI.a share is entitled to a 1/10 vote per share. This post focuses on [...]
In July 2022, Rollins (ROL) announced its Board had approved the company's 2023 CEO succession plan. In August 2022, ROL named a new CFO. Since such time, the quality of financial information has improved. I last reviewed ROL in this February 20, 2023 post at which time the company had just released its Q4 and [...]
In late 2020, I looked at Zoom Video Communications, Inc. (ZM) and quickly determined shares were grossly overvalued. A few days ago, someone asked me for my opinion of the company. With the release of Q2 and YTD2024 results after the August 21 market close, I now revisit ZM. NOTE: ZM is NOT to be [...]
In my May 10 post, I disclose my decision to initiate a 200-share Agilent Technologies (A) position @ ~$127/share in a 'Core' account within the FFJ Portfolio. On June 9 and July 6, I acquired an additional 100 shares @ ~$115.96/share and ~$118.48/share. These purchases lowered my average cost to ~$122.35 and brought my total [...]
In my August 10 guest post at Dividend Power, I explain why I have no exposure to T. Rowe Price (TROW) and why I have no intention of initiating a position. In an industry where participants are heavily dependent on Assets Under Management (AUM) and performance track record relative to peers, TROW's struggles are [...]
I last reviewed Broadridge Financial Solutions (BR) in this November 29, 2022 post at which time it had recently released its Q1 2022 results. With the release of the Q4 and FY2023 results and FY2024 guidance, I take this opportunity to revisit this existing holding. Business Overview BR operates in two reportable segments, Investor Communication [...]